Atea Pharmaceuticals Inc (AVIR)
4.055
+0.16
(+4.24%)
USD |
NASDAQ |
May 13, 16:00
4.055
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Price: 4.055 for May 13, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 10, 2024 | 3.91 | 3.985 | 3.88 | 3.89 | 155489.0 |
May 09, 2024 | 3.92 | 4.02 | 3.892 | 3.93 | 207864.0 |
May 08, 2024 | 3.89 | 3.935 | 3.853 | 3.93 | 127937.0 |
May 07, 2024 | 4.00 | 4.00 | 3.905 | 3.94 | 143692.0 |
May 06, 2024 | 3.96 | 4.00 | 3.885 | 4.00 | 288222.0 |
May 03, 2024 | 3.89 | 3.96 | 3.795 | 3.96 | 164714.0 |
May 02, 2024 | 3.86 | 3.865 | 3.78 | 3.83 | 165722.0 |
May 01, 2024 | 3.73 | 3.935 | 3.72 | 3.85 | 405230.0 |
Apr 30, 2024 | 3.70 | 3.765 | 3.69 | 3.70 | 227778.0 |
Apr 29, 2024 | 3.70 | 3.77 | 3.695 | 3.71 | 175467.0 |
Apr 26, 2024 | 3.71 | 3.72 | 3.652 | 3.71 | 143066.0 |
Apr 25, 2024 | 3.68 | 3.745 | 3.67 | 3.69 | 174652.0 |
Apr 24, 2024 | 3.71 | 3.735 | 3.68 | 3.70 | 196517.0 |
Apr 23, 2024 | 3.68 | 3.82 | 3.68 | 3.73 | 180547.0 |
Apr 22, 2024 | 3.71 | 3.76 | 3.66 | 3.67 | 345154.0 |
Apr 19, 2024 | 3.69 | 3.77 | 3.671 | 3.72 | 217749.0 |
Apr 18, 2024 | 3.70 | 3.755 | 3.68 | 3.70 | 267759.0 |
Apr 17, 2024 | 3.73 | 3.785 | 3.71 | 3.71 | 251669.0 |
Apr 16, 2024 | 3.73 | 3.87 | 3.715 | 3.74 | 129117.0 |
Apr 15, 2024 | 3.78 | 3.86 | 3.72 | 3.76 | 219443.0 |
Apr 12, 2024 | 3.82 | 3.89 | 3.73 | 3.76 | 171066.0 |
Apr 11, 2024 | 3.79 | 3.885 | 3.79 | 3.85 | 158848.0 |
Apr 10, 2024 | 3.73 | 3.78 | 3.73 | 3.77 | 266678.0 |
Apr 09, 2024 | 3.78 | 3.85 | 3.77 | 3.81 | 116700.0 |
Apr 08, 2024 | 3.80 | 3.83 | 3.74 | 3.76 | 216739.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.80
Minimum
Nov 22 2023
88.44
Maximum
Feb 08 2021
14.72
Average
6.26
Median
Mar 09 2022
Price Benchmarks
CEL-SCI Corp | 1.415 |
AIM ImmunoTech Inc | 0.421 |
IGC Pharma Inc | 0.5225 |
NovaBay Pharmaceuticals Inc | 0.0809 |
Protalix BioTherapeutics Inc | 1.145 |
Price Related Metrics
PS Ratio | 0.9624 |
Price to Book Value | 0.6147 |
Earnings Yield | -40.44% |
Market Cap | 341.29M |
Operating PE Ratio | 2.444 |
Normalized PE Ratio | 2.982 |